Resources Contact Us Home Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE     Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety Image Number 13 for United States Patent #8119616. The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.       Recently Added Patents Blank arrangement Methods of making a semiconductor memory device Holder for inspection lamp Lignocellulose fiber-resin composite material HDAG backup system with variable retention Integrated circuit having back gating, improved isolation and reduced well resistance and method to fabricate same Method and apparatus for determining anticoagulant therapy factors   Randomly Featured Patents Vent pipes for cinder block walls Embedded die package on package (POP) with pre-molded leadframe Tubular connection with slotted threads Visual encoding of a content address to facilitate data transfer in digital devices Umbrella-type tent apparatus and method Self retaining fluid filter Flash memory devices and erasing methods thereof Pacing lead with improved anchor mechanism Charged particle beam lithography apparatus for forming pattern on semi-conductor Waterborne (meth) acrylic latex polymers for release © 2006-2008 PatentGenius. All Rights Reserved.